What PeptIQ Users Should Watch If someone is tracking retatrutide in a kidney-aware workflow, the most useful data are not just scale weight and "how it felt." Better tracking includes: Dose changes and escalation timing Nausea, reflux, constipation, or vomiting Daily fluid intake and appetite changes Blood pressure trends Weight trend and waist trend Protein intake Creatinine, eGFR, BUN, and urine markers when available Concomitant medications that affect fluid balance or renal function That kind of logging helps separate true benefit from side effects that look like progress at first and create problems later
A psyllium fiber-enriched meal strongly attenuates postprandial gastrointestinal peptide release in healthy young adults
Cardiovascular risk factors Weight loss achieved with retatrutide has been associated with improvements in several cardiovascular risk markers, including: lower blood pressure improved cholesterol profiles reduced triglyceride levels better insulin sensitivity As with other GLP-1-based therapies, dedicated cardiovascular outcome trials are needed to establish whether these improvements lead to reductions in heart attack, stroke or cardiovascular death
Meeran, K
These are all areas impacted by declining estrogen
When we eat certain types of food, mainly ultra-processed foods, we get a dopamine rush, and before you know it, youre reaching for the biscuit tin without even thinking